Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Phase I Study to Investigate Tolerability and Efficacy of ALECSAT Administered to Glioblastoma Multiforme Patients (ALECSAT-GBM)

This study has been completed.
Information provided by (Responsible Party):
CytoVac A/S Identifier:
First received: April 27, 2012
Last updated: June 3, 2016
Last verified: June 2016
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: April 2013
  Primary Completion Date: November 2012 (Final data collection date for primary outcome measure)